Conestoga Capital Advisors’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.5M Buy
1,623,700
+448,290
+38% +$12.5M 0.79% 37
2026
Q1
$43M Buy
+1,175,410
New +$46.4M 0.86% 37

Other funds holding AORT

Conestoga Capital Advisors's AORT Position: Q2 2026 in Review

Conestoga Capital Advisors increased its Artivion (AORT) stake by 38% in Q2 2026, buying an estimated $12.5M and bringing the position to 1,623,700 shares worth $36.5M. The position accounts for 0.79% of the portfolio, ranked #37.

Conestoga Capital Advisors first reported a position in AORT in Q1 2026 and has held it in 2 quarters since. The position peaked at $43M in Q1 2026. 206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • Conestoga Capital Advisors held 1,623,700 shares of Artivion worth $36.5M as of Q2 2026.
  • Conestoga Capital Advisors bought 448,290 Artivion shares in Q2 2026, an estimated $12.5M.
  • Artivion made up 0.79% of Conestoga Capital Advisors's portfolio in Q2 2026, its #37 holding.
  • Conestoga Capital Advisors first reported a position in Artivion in Q1 2026 and has held it in 2 quarters since.
  • Conestoga Capital Advisors's Artivion position peaked at $43M in Q1 2026.
  • 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on Conestoga Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.